Analyst Research Report Snapshot

Title:

BENITEC BIOPHARMA - SILENCE COULD BE GOLDEN

Price:

$10.00

Provider:

Edison Investment Research

Date:

25 Feb 2014

Pages:

2

Type:

AcrobatPDF

Companies referenced:

BLT.AX

Available for Immediate Download
Summary:

Benitec Biopharma has a gene-silencing technology, known as ddRNAi, which offers advantages over competing silencing techniques. The pipeline consists of six in-house. The proposed raise of A$31.5m would mean the company is funded beyond the completion of a key Phase I/IIa trial (due to start in 2014) for its lead project, TT-034 for Hepatitis C.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.